According to data from the Health Insurance Review and Assessment Service in 2023, there are an estimated 15,000 patients ...

CT scans done an average of 145 days after COVID infection were analyzed and showed 39% pulmonary fibrosis and 22% inflammatory changes in the 35 patients tested.

Dr Jeffrey Swigris and Janet Talbert discuss the current understanding of the genetics of pulmonary fibrosis, explore the identified genetic pathways, and discuss future research directions.

Interstitial lung abnormalities (ILAs) are parenchymal lung changes found on high-resolution CT. In routine use of high-resolution CT, non-specific findings are frequently reported, which has prompted ...

By studying long COVID patients with abnormal lung CT scans, Northwestern Medicine researchers may have found a cellular commonality in many types of pulmonary fibrosis, which could lead to ...

Panelists discuss how progressive pulmonary fibrosis (PPF) and idiopathic pulmonary fibrosis (IPF), though distinct in etiology, share a common trajectory of irreversible lung scarring and ...

The global progressive pulmonary fibrosis (PPF) treatment market is projected to be valued at USD 4,044.6 Million in 2025 and is expected to reach USD 8,182.4 Million by 2035, registering a CAGR of 7.

A new drug for pulmonary fibrosis has reduced disease progression by more than 50% over a 52-week treatment in two clinical trials. Pulmonary fibrosis is a very serious disease, with a life ...

In this randomized controlled trial, treatment with nerandomilast led to slower declines in forced vital capacity (FVC) in patients with progressive pulmonary fibrosis over 52 weeks 2. The occurrence ...

The two companies will collaborate on the use of e-Lung to accelerate the diagnosis and improve access to treatment for people living with pulmonary fibrosis from CT scans.

The Phase II study is evaluating Cumberland's ifetroban product candidate in patients with idiopathic pulmonary fibrosis (IPF), the most common form of progressive fibrosing interstitial lung disease.

So even if someone smokes, their pulmonary fibrosis would be yet labelled idiopathic pulmonary fibrosis? If they meet the criteria -- their CT has a certain appearance.